Tolerance of benznidazole in treatment of Chagas' disease in adults

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4896-4899

  Pinazo, María Jesús ^a   Muñoz, José ^a   Posada, Elizabeth ^a   López Chejade, Paulo ^b   Gállego, Montserrat ^b   Ayala, Edgar ^c   Del Cacho, Elena ^a   Soy, Dolors ^a   Gascon, Joaquim ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE;

ADOLESCENT; ADULT; ANOREXIA; APHTHOUS STOMATITIS; ARTHRITIS; ARTICLE; BLOATING; CHAGAS DISEASE; DIARRHEA; DRUG EFFECT; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSHIDROSIS; DYSPHAGIA; EDEMA; EPIGASTRIC PAIN; ERYTHEMA NODOSUM; FEMALE; FEVER; HEADACHE; HEARING IMPAIRMENT; HEARTBURN; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; RASH; SPAIN; TRYPANOSOMA CRUZI; URTICARIA; VOMITING; WEAKNESS;

ADOLESCENT; ADULT; CHAGAS DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; YOUNG ADULT;

EID: 78049262495     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00537-10     Document Type: Article

References (25)

1. Cançado, J. R. 2002. Long term evaluation of etiological treatment of Chagas' disease with benznidazole. Rev. Inst. Med. Trop. Sao Paulo 44:29-37.
2. Carpintero, D. J. 1983. Uso del ácido tióctico para la prevención de los efectos secundarios provocados por el benznidazol en pacientes con enfermedad de Chagas crónica. Medicina (B. Aires). 43:285-290.
3. Coura, R. J., and S. L. de Castro. 2002. A critical review on Chagas' disease chemotherapy. Mem. Inst. Oswaldo Cruz 97:3-24.
4. de Andrade, A. L., F. Zicker, R. M. de Oliveira, S. Almeida Silva, A. Luquetti, L. R. Travassos, I. C. Almeida, S. S. de Andrade, J. G. de Andrade, and C. M. Martelli. 1996. Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348:1407-1413.
5. Fabbro, D. L., M. L. Streiger, E. D. Arias, M. L. Bizai, M. del Barco, and N. A. Amicone. 2007. Trypanocide treatment among adults with chronic Chagas' disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Rev. Soc. Bras. Med. Trop. 40:1-10.
6. Fernandes, C. D., F. M. Tiecher, M. M. Balbinot, D. B. Liarte, D. Scholl, M. Steindel, and A. Romanha. 2009. Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up. Mem. Inst. Oswaldo Cruz 104:27-32.
7. Ferreira, H. D. 1976. Clinico-therapeutic trial with benzonidazole in Chagas' disease. Rev. Inst. Med. Trop. Sao Paulo. 8:357-364.
8. Gascon, J., C. Bern, and M. J. Pinazo. 2010. Chagas' disease in Spain, the United States and other non-endemic countries. Acta Trop. 115:22-27.
9. Levi, G. C., V. Amato Neto, and I. F. Sant'anna. 1975. Análise de manifestaçoes colaterais devidas ao uso do medicamento Ro 7-1051, nitroimidazo zólico preconizado para tentativas de tratamento espscífico na doença de Chagas. Rev. Inst. Med. Trop. Sao Paulo 18:357-364.
10. Marin-Neto, J. A., A. Rassi, Jr., C. A. Morillo, A. Avezum, S. J. Connolly, S. Sosa-Estani, F. Rosas, and S. Yusuf. 2008. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am. Heart J. 156:37-43.
11. Muñoz, J., J. Gómez i Prat, M. Gállego, F. Gimeno, B. Treviño, P. López-Chejade, O. Ribera, L. Molina, S. Sanz, M. J. Pinazo, C. Riera, E. J. Posada, G. Sanz, M. Portús, and J. Gascon. 2009. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas' disease in Barcelona (Spain). Acta Trop. 111:51-55.
12. Organización Panamericana de la Salud. 2006. Estimación cuantitativa de la enfermedad de Chagas en las Americas. Organización Panamericana de la Salud (OPS), Montevideo, Uruguay.
13. Piron, M., R. Fisa, N. Casamitjana, P. López-Chejade, L. Puig, M. Vergés, J. Gascón, J. Gómez i Prat, M. Portus, and S. Sauleda. 2007. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop. 103:195-200.
14. Prata, A. 2001. Clinical and epidemiological aspects of Chagas' disease. Lancet Infect. Dis. 1:92-100.
15. Raaflaub, J., and W. H. Ziegler. 1979. Multiple-dose kinetics of the trypanosomicide benznidazole in man. Drug Res. 29:1611-1614.
16. Schijman, A. G., J. Altcheh, J. M. Burgos, M. Biancardi, M. Bisio, M. J. Levin, and H. Freilij. 2003. Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. J. Antimicrob. Chemother. 52:441-449.
17. Sosa Estani, S., A. Armenti, G. Araujo, R. Viotti, B. Lococo, B. Ruiz Vera, C. Vigliano, A. M. de Rissio, and E. L. Segura. 2004. Treatment of Chagas' disease with benznidazole and thioctic acid. Medicina (B. Aires) 64:1-6.
18. Sosa Estani, S., and E. L. Segura. 2006. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr. Opin. Infect. Dis. 19:583-587.
19. Sosa Estani, S., E. L. Segura, A. M. Ruiz, E. Velazquez, B. M. Porcel, and C. Yampotis. 1998. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am. J. Trop. Med. Hyg. 59:526-529.
20. Stata Corp. 2007. Stata Statistical Software, release 10. StataCorp LP, College Station, TX.
21. Viotti, R., C. Vigliano, H. Armenti, and E. Segura. 1994. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. Heart J. 127:151-162.
22. Viotti, R., C. Vigliano, B. Lococo, M. G. Alvarez, M. Petti, G. Bertochi, and A. Armenti. 2009. Side effects of benznidazole as treatment in chronic Chagas' disease: fears and realities. Expert Rev. Anti Infect. Ther. 7:157-163.
23. Viotti, R., C. Vigliano, B. Lococo, G. Bertocchi, M. Petti, M. G. Alvarez, M. Postan, and A. Armenti. 2006. Long-term cardiac outcomes of treating Chagas' disease with benznidazole versus non treatment. Ann. Inter Med. 144:724-734.
24. World Health Organization (WHO). 2002. Control of Chagas' disease. World Health Organ. Tech. Rep. Ser. 905:1-109.
25. Yun, O., M. A. Lima, T. Ellman, W. Chambi, S. Castillo, L. Flevaud, P. Roddy, F. Parreño, P. Abajar Viñas, and P. P. Palma. 2009. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas' disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières. PLoS Negl. Trop. Dis. 3:e488.